Pharmacology, Toxicology and Pharmaceutical Science
Psoriatic Arthritis
100%
Psoriasis
32%
Diseases
22%
Disease Activity
19%
Placebo
11%
Disease Modifying Antirheumatic Drug
10%
Clinical Trial
8%
Cohort Study
7%
Randomized Controlled Trial
7%
Guselkumab
7%
Tumor Necrosis Factor Inhibitor
7%
Biological Product
6%
Arthritis
6%
Medicine and Dentistry
Psoriatic Arthritis
80%
Psoriasis
31%
Disease Activity
16%
Diseases
15%
Quality of Life
9%
Primary Health Care
7%
Disease Modifying Antirheumatic Drug
7%
Patient-Reported Outcome
7%
Rheumatology
6%
Biological Product
6%
Musculoskeletal Disease
5%
Clinical Trial
5%
TNF Inhibitor
5%
Randomized Controlled Trial
5%
Placebo
5%
Arthritis
5%
Nursing and Health Professions
Psoriatic Arthritis
47%
Psoriasis
10%
Diseases
9%
Disease Activity
8%
Systematic Review
6%
Primary Medical Care
6%
Quality of Life
5%
Clinical Practice
5%
Patient-Reported Outcome
5%